Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve Board Meeting intimation
Awaiting price reaction for this filing.
Dolphin Medical Services Ltd has informed BSE that its Board of Directors will meet on 11 November 2025. The key agenda is to consider and approve the Un-Audited Financial Results for the quarter and half year ended 30 September 2025, in line with SEBI Listing Regulations. No financial figures or business details are disclosed in this filing — it is a routine advance intimation under Regulation 29. The company is based in Hyderabad and listed on BSE under script code 526504.
This is a standard regulatory notice and has no direct impact on the stock price. Investors should wait for the actual Q2/H1 FY26 results to be released on or after 11 November 2025 to gauge the company's earnings performance for the period.